Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001831216-26-000003

CH. DISCOV. & NON-CLIN DEV OFF sold 110,000 shares at an average $28.25 ($3,107,229)

  • CH. DISCOV. & NON-CLIN DEV OFF acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-12 Sale −10,000 $28.34 $283,400 144,846 I
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-13 Option exercise +50,000 $4.87 $243,500 592,761 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-13 Sale −49,800 $27.60 $1,374,480 542,961 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-13 Sale −200 $28.49 $5,698 542,761 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-14 Option exercise +50,000 $4.87 $243,500 592,761 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-14 Sale −14,997 $28.60 $428,914 577,764 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-14 Sale −35,003 $28.99 $1,014,737 542,761 D
Derivatives
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-13 Option exercise · Stock Option (Right to Buy) −50,000 100,000 D
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-01-14 Option exercise · Stock Option (Right to Buy) −50,000 50,000 D
Open-market sales · 110,000 sh · avg $28.25 · $3,107,229
Loading xslF345X05/form4-01142026_090101.xml…